Ruthenium(II) complexes feature prominently in the development
of agents for photoactivated chemotherapy; however, the excited-state
mechanisms by which photochemical ligand release operates remain unclear.
We report here a systematic experimental and computational study of
a series of complexes [Ru(bpy)2(N∧N)]2+ (bpy = 2,2′-bipyridyl; N∧N = bpy
(1), 6-methyl-2,2′-bipyridyl (2),
6,6′-dimethyl-2,2′-bipyridyl (3), 1-benzyl-4-(pyrid-2-yl)-1,2,3-triazole
(4), 1-benzyl-4-(6-methylpyrid-2-yl)-1,2,3-triazole (5), 1,1′-dibenzyl-4,4′-bi-1,2,3-triazolyl (6)), in which we probe the contribution to the promotion of
photochemical N∧N ligand release of the introduction
of sterically encumbering methyl substituents and the electronic effect
of replacement of pyridine by 1,2,3-triazole donors in the N∧N ligand. Complexes 2 to 6 all release
the ligand N∧N on irradiation in acetonitrile solution
to yield cis-[Ru(bpy)2(NCMe)2]2+, with resultant photorelease quantum yields that at
first seem counter-intuitive and span a broad range. The data show
that incorporation of a single sterically encumbering methyl substituent
on the N∧N ligand (2 and 5) leads to a significantly enhanced rate of triplet metal-to-ligand
charge-transfer (3MLCT) state deactivation but with little
promotion of photoreactivity, whereas replacement of pyridine by triazole
donors (4 and 6) leads to a similar rate
of 3MLCT deactivation but with much greater photochemical
reactivity. The data reported here, discussed in conjunction with
previously reported data on related complexes, suggest that monomethylation
in 2 and 5 sterically inhibits the formation
of a 3MCcis state but promotes the population
of 3MCtrans states which rapidly deactivate 3MLCT states and are prone to mediating ground-state recovery.
On the other hand, increased photochemical reactivity in 4 and 6 seems to stem from the accessibility of 3MCcis states. The data provide important insights
into the excited-state mechanism of photochemical ligand release by
Ru(II) tris-bidentate complexes.